Funds and ETFs Eris Lifesciences Limited

Equities

ERIS

INE406M01024

Pharmaceuticals

Market Closed - NSE India S.E. 05:13:51 15/05/2024 pm IST 5-day change 1st Jan Change
888 INR +1.38% Intraday chart for Eris Lifesciences Limited +2.22% -2.42%

ETFs positioned on Eris Lifesciences Limited

Name Weight AuM 1st Jan change Investor Rating
0.01% 112 M€ +5.68% -
0.00% 45 M€ 0.00% -
0.00% 7 M€ +6.66% -
Eris Lifesciences Limited is an India-based company that is primarily engaged in the manufacturing and marketing of pharmaceutical products. The Company’s manufacturing plant is located in Guwahati, Assam. Its therapeutic areas include oral diabetes care, cardiac care, pain/analgesics, gynecology, gastrointestinal, central nervous system (CNS), and vitamins, minerals, and nutrients (VMN). The Company's brands include Advog 0.2, Atorsave Gold 10, Baga NT 100, Calshine 60K Tablet, Carpela, Cilentra Plus 5, Cognix, D1000cal, Enoxsave 60, Glimisave M 4 forte, Levroxa 1000, Mac Rabonik Plus, Glimisave, Eritel, Renerve, Tendia, Olmin, Rabonik, Tayo, Cyblex, Lnbloc, Remylin, Zomelis, Crevast, Atorsave, Ginkocer and Metital. The Company’s wholly owned subsidiaries include Kinedex Healthcare Private Limited, Aprica Healthcare Limited, and Eris Healthcare Private Limited.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
888 INR
Average target price
1,081 INR
Spread / Average Target
+21.69%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. ERIS Stock
  4. Funds and ETFs Eris Lifesciences Limited
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW